Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection Abstract Purpose: To evaluate pseudophakic cystoid macular edema.

Slides:

Advertisements

Similar presentations

Bevacizumab (Avastin): 2 year results in choroidal neovascularization (CNV) secondary to pathologic myopia (PM). regory S. Brinton; Sayed S E H Saif; M.

Advertisements

A Comparison between Fluorescein Angiography and Optical Coherence Tomography Findings in Patients with Clinically Significant Macular Edema KoriAnne Elkins.

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema: Potential impact of.

CATARACT SUEGRY AND DIABETES Indications of surgery: 1) Visual loss 2)Surveillance of retinopathy 3)Laser therapy.

Sérgio Kwitko, Tiago Lansini, Andressa P Stolz, Diane R Marinho Authors have no financial interest in the subject matter of this poster.

Are Network Results Regarding Ocular Coherence Tomography (OCT) Relevant to Clinical Practice and Clinical Trials? Sponsored by the National Eye Institute,

Optical Coherence tomography Imaging of Spontaneous closure of Psuedophakic full thickness macular hole, 8 months post operative Dr. Jenin Patel Lotus.

Anupama Kotha 1, Simar J. Singh 1, William B. Trattler 1,2, Carlos Buznego 1,2 The authors have no financial interest in the subject matter of this poster.

The Effect of the Restor Multifocal IOL on Frequency Doubling Perimetry Elizabeth Yeu, MD1, Elizabeth Woznak, BS2, Nicole Kesten, BS2, Steven VL Brown,

The Diabetic Retinopathy Clinical Research Network Comparison of Visual and OCT Outcomes in Eyes with and without Prior Vitrectomy Receiving Anti- Vascular.

Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Aref.

Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Intraocular Pressure Risk Factors Parekh A, Srivastava S, Bena J, Albini T, Nguyen.

European Association for Vision and Eye Research – Crete, Oct 5-8, 2011 Ranibizumab for the Treatment of Exudative Age-Related Macular Degeneration Associated.

Phacoemulsification in eyes with previous anterior chamber phakic IOL surgery Walton Nosé, MD, PhD 1,2 Adriana dos Santos Forseto, MD 1 Mariana Ávila,

Laser-Ranibizumab-Triamcinolone for DME Study DRCR.net Protocol I

Retinal nerve fiber layer thickness change in patients with wet AMD treated with ranibizumab, short term results Advantages: To determine the effect of.

1 Justin H. Townsend, MD Harry W. Flynn, Jr., MD The authors have no financial interest in the subject matter of this poster Treatment of Endophthalmitis.

Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.

Phase IIIb Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration PIER Study Year 1 Regillo CD,

Effect of Corneal Thickness on Selective Laser Trabeculoplasty to Decrease Intraocular Pressure as Primary or Secondary Treatment of Glaucoma ASCRS 2010.

Assessment of macular thickness and function by optical coherence tomography and multifocal electroretinogram in uncomplicated cataract surgery Yang Li,

Intracameral Amphotericin B in Management of Candida Glabrata Keratouveitis after Penetrating Keratoplasty Petra Schollmayer, Aleksandra Kraut, Mojca Globocnik-Petrovic,

A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study.

Foreign body reaction against intracameral Triamcinolone: Clinicopathological case report Amy L. Wong, MRCSEd; Hunter K. L. Yuen FRCS; Christopher K.S.

The Diabetic Retinopathy Clinical Research Network

Endothelial Keratoplasty in Patients With an Anterior Chamber Intraocular Lens: A Montreal Experience Georges M. Durr, MD 1,2 Johanna Choremis, MD, FRCSC.

Clinical outcome of DALK in Keratoconus – A one year follow up

Prospective, Randomized, Double-Blind Study Comparing Nepafenac 0.1% (Nevanac™) and Bromfenac Sodium 0.09% (Xibrom™) in Post-Op Cataract Patients Hon-Vu.

Efficacy of Bromfenac 0.09% in Prevention and Treatment of Pseudophakic CME When Used Preoperatively and Postoperatively by Melissa M. Cable, MD, FAAO,

The authors have no financial interest in the subject matter of this poster. FINANCIAL DISCLOSURES.

Effect of Race on Selective Laser Trabeculoplasty  1st author has no financial interest in the subject matter of this poster.  2nd and 3rd co-authors.

Introduction  Selective Laser Trabeculoplasty (SLT) uses a Q-Switched frequency- doubled (532 nm), low energy Nd:YAG laser, which targets melanocytes.

Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,

*Kagithane State Hospital,Department of Ophthalmology,Istanbul, Turkey DR.GÖKHAN KAYA *Kagithane State Hospital,Department of Ophthalmology, No author.

Outcomes of Transscleral Sulcus Fixation of Intraocular Lenses through a 2.4-mm Incision with an Injector System: 1-Year Follow-Up Akiko Masai, MD, Tomoichiro.

COMPARATIVE LONG TERM RESULTS OF THREE DIFFERENT THERAPIES FOR MYOPIC CHOROIDAL NEOVASCULARIZATION J.A. Montero, J.M. Ruiz-Moreno VISSUM, Alicante Institute.

Sponsored by the National Eye Institute,

LogMAR-Analysis of multifocal intraocular lenses: Clinical performance A. Mannsfeld, I.-J. Limberger, A. Ehmer, M.P. Holzer, G. U.Auffarth International.

Effect of East Asian Race on Selective Laser Trabeculoplasty ASCRS 2011 Minerva Kim Johns Hopkins University Lawrence F. Jindra, MD Columbia University.

Effect of Refractive State on Selective Laser Trabeculoplasty ASCRS 2011 Kevin Lai Stony Brook University School of Medicine Elaine M. Miglino Floral Park.

DSEK for the treatment of endothelial disease in India -Initial Experience in 80 eyes- Authors have no financial interest Dr Ashish Nagpal MD, FRCS Dr.

Post-Operative Management of Vitreous Adhesion after DSAEK with YAG Laser Vitreolysis Sherif Idris 1, Ahmed Al-Ghoul 2 MD FRCSC DipABO 1 University of.

Jae Woo Kim M.D. ; Sung Kun Chung M.D. Nam Ho Baek M.D. Department of Ophthalmology and Visual Science, The Catholic University of Korea Clinical Result.

Simulated Experiments on IOL Power Calculation Using Anterior Segment OCT Dong Hyun Jo, M.D., 1,2 Mee Kum Kim, M.D., 1,2 Won Ryang Wee, M.D. 1,2 1 Department.

COMPARATIVE EFFICACY OF INTRAVITREAL BEVACIZUMAB AND RANIBIZUMAB IN THE TREATMENT OF DIABETIC MACULAR OEDEMA J.A. Montero, J.M. Ruiz-Moreno VISSUM, Alicante.

Effect of Previous Argon Laser Trabeculoplasty on Selective Laser Trabeculoplasty ASCRS 2011 Lawrence F. Jindra, MD Columbia University Winthrop University.

Liquifaction Method and Extent of Posterior Capsule Opacification: Two-Year Follow-up Marie Kalfertova, Mariya Burova, Pavel Rozsival, Nada Jiraskova Nada.

Long-term results of Phakic Refractive Lens (PRL™) implantation in high myopic eyes. Ioannis G. Pallikaris 1, 2, MD, PhD, Maria I. Kalyvianaki 1, MD, PhD,

CATT objectives To determine whether off-lable “Avastin” works as well as approved medication for neovascular AMD- “Lucentis” To evaluate how often treatment.

Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: A Prospective Trial of Infliximab Therapy for Refractory.

Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Inhibition of Neovascularization but Not Fibrosis.

Reproducibility of retinal thickness measurements in eyes with

A Paul, C Louize,S Shafquat Dudley Hospitals NHS Foundation Trust

Andrés Suárez-Campo, María López-Valladares

Analysis of Macular Edema after Cataract Surgery in Patients with Diabetes Using Optical Coherence Tomography Stephen J. Kim, MD, Robert Equi, MD, Neil.

Role of vitrectomy the treatment of diabetic macular edema

Outer Retinal Tubulation

RESOLUTION OF REFRACTORY CYSTOID MACULAR EDEMA OF BIRDSHOT CHORIORETINOPATHY WITH TOCILIZUMAB AND AFLIBERCEPT CASE REPORT Mónica Martínez Díaz, José Gregorio.

Correlation between visual acuity

World Cornea Congress VI April 7-9, 2010

Copyright © 2004 American Medical Association. All rights reserved.

The Diabetic Retinopathy Clinical Research Network

Crosslinking with Simultaneous Implantation of Intrastromal Corneal Ring Segments in Keratoconus: Safe and Efficacy Author: Luiz Antonio de Brito Martins.

Opacification of the optic of an Akeos Adapt® intraocular lens

J. Fernando Arevalo, MD FACS Clínica Oftalmológica Centro Caracas

Clinical results of the aphakia correction using iris-fixated anterior chamber intraocular lens (Artisan) Authors have no financial interest Luis Izquierdo.

Use of silicon hydrogel contact lenses at photorefractive keratectomy postoperative Autors: Gustavo Victor, Luiz Humberto Teixeira Bóro, Daniela Akemi.

Figure 3: Female patient, 57 years old

Punctual plug and dry eye after photorefractive keratectomy

Karen Chia, MD Chan Tat Keong, MD Peter Tseng, MD Doric Wong, MD

Presentation transcript:

Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection Abstract Purpose: To evaluate pseudophakic cystoid macular edema (CME) by optical coherence tomography (OCT) and determine the efficacy of intravitreal triamcinolone acetonide injections. Methods: In this nonrandomized retrospective study, 10 eyes of 09 patients with persistent pseudophakic CME were treated with single triamcinolone acetonide injection and were followed up for 6 months. All patients underwent complete ophthalmologic examination including determination of best-corrected visual acuity, slit-lamp examination, tonometry, funduscopy and OCT recorded before and after 10, 20 days and 3 months the injection. Results: Visual acuity and value increased in all patients after intravitreal triamcinolone acetonide injections. OCT showed improvement of the retinal thickness in the macular area. There was no increase of intraocular pressure. Conclusion: Intravitreal triamcinolone acetonide injection is a promising therapeutic tool for chronic pseudophakic edema resistant to other medical treatment. However, further study is needed to assess the treatment’s long-term efficacy, its safety, and the need for retreatment. There is no significant difference in the use of acrylic lenses and silicon lens in our results. Gonçalves CA..; Garcia, Marcos A..; Odloak CM. ;Campos, Paloma C.; Boro, Luiz Humberto T.; Miyamoto, Daniela A.; Going, Mayalu C. Retina Sector- Department of Ophthalmology Ana Costa Hospital of Santos - HAC REFERENCES 1. Kraff MC, Sanders DR, Jampol LM, Lieberman HL. Factors affecting pseudophakic macular edema. Five randomized trials. Am Intraocular Implant Soc S J. 1999;11: Wright PL, Wilkinson CP, Balyeat HD, Popham J, Reinke M. Angiographic cystoid macullar edema after posterior chamber lens implantation. Arch Ophthalmol. 1988;106(6): Irvine SR. Cystoid maculopathy. Surv Ophthalmol. 1976;21: Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol. 2001;119: nAGEEYERACESEXBCVA BEFOREBCVA AFTERDISEASESLIO TREATMENT 1`78 ODWHITEMALE20/8020/20DMACRYLIC 265 OEWHITEFEMALE20/10020/30NONESILICON 369 AOWHITEFEMALE20/ /6020/ /20DMACRYLIC 472 OEWHITEMALE20/8020/20NONEACRYLIC 581 OEWHITEMALE20/7020/25DMACRYLIC 670 ODWHITEMALE20/6020/25NONESILICON 769 OEWHITEFEMALE20/7020/30NONESILICON 880 ODWHITEMALE20/8020/20NONESILICON 950 ODWHITEMALE20/6020/20NONEACRYLIC

Gonçalves CA.; Garcia,MA.; Odloak CM. ; Campos, PC.; Boro, LHT.; Miyamoto, DA.; Going, MC. Retina Sector- Department of Ophthalmology Ana Costa Hospital of Santos – HAC There is no financial interest by the author and coauthor’s in this poster issue. Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection

Purpose: To evaluate pseudophakic cystoid macular edema (CME) by optical coherence tomography (OCT) and determine the efficacy of intravitreal triamcinolone acetonide injections. Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection

Methods: In this nonrandomized retrospective study, 10 eyes of 09 patients with persistent pseudophakic CME were treated with single triamcinolone acetonide injection and were followed up for 6 months. All patients underwent complete ophthalmologic examination including determination of best-corrected visual acuity, slit-lamp examination, tonometry, funduscopy and OCT recorded before and after 10, 20 days and 3 months the injection. Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection

Results: Visual acuity and value increased in all patients after intravitreal triamcinolone acetonide injections. OCT showed improvement of the retinal thickness in the macular area. There was no increase of intraocular pressure. There is no significant difference in the use of acrylic lenses and silicon lens in our result Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection

Conclusion: Intravitreal triamcinolone acetonide injection is a promising therapeutic tool for chronic pseudophakic edema resistant to other medical treatment. However, further study is needed to assess the treatment’s long-term efficacy, its safety, and the need for retreatment. Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection

nAGEEYERACESEXBCVA BEFOREBCVA AFTERDISEASESLIO TREATMENT 1`78 ODWHITEMALE20/8020/20DMACRYLIC 265 OEWHITEFEMALE20/10020/30NONESILICON 369 AOWHITEFEMALE20/ /6020/ /20DMACRYLIC 472 OEWHITEMALE20/8020/20NONEACRYLIC 581 OEWHITEMALE20/7020/25DMACRYLIC 670 ODWHITEMALE20/6020/25NONESILICON 769 OEWHITEFEMALE20/7020/30NONESILICON 880 ODWHITEMALE20/8020/20NONESILICON 950 ODWHITEMALE20/6020/20NONEACRYLIC Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection